Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Use of complementary and alternative medicine by patients with end-stage renal disease on haemodialysis in Trinidad: A descriptive study

Author: Mandreker Bahall

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

Despite the paucity of scientific evidence, complementary and alternative medicine (CAM) is widely used for the prevention and treatment of illness, holistic care, and counteracting the adverse effects of conventional medicine (CM). This study investigates the use of CAM by patients with end-stage renal disease (ESRD) on haemodialysis.

Methods

This quantitative study was conducted from November 1, 2014 to December 31, 2014 in the haemodialysis unit at San Fernando General Hospital (San Fernando, Trinidad). Face-to-face questionnaire-based interviews were held with101of 125 eligible patients (response rate, 80.5%) at the chairside during haemodialysis. The completed questionnaires were entered into a secure computer database. Data analysis included descriptive analysis, χ2 tests, and binary logistic regression analysis.

Results

A minority of the patients were CAM users (n = 19; 18.8%). All 19 CAM users took medicinal herbs, 78.9% (n = 15) used spiritual therapy, and 10.5% (n = 2) used alternative systems. Medicinal tea (n = 15; 78.9%), garlic (Allium sativum) (n = 17; 73.7%), and ginger (Zingiber officinale roscoe) (n = 13; 68.4%) were the most commonly used medicinal herbs. Seven (36.8%) patients used Chinese herbal medicines and 3 (15.8%) patients used Aloe vera. All CAM users were willing to use CAM without supervision or monitoring by their doctors while receiving CM. The use of CAM could not be predicted by age, sex, ethnicity, education, religion, marital status, or employment. Nearly all (98%) patients were satisfied with CAM. More than one-third (36.8%) of patients did not disclose their use of CAM to their doctors, who were generally indifferent to such therapy.

Conclusions

The use of CAM by patients with ESRD was relatively infrequent. All patients used medicinal herbs, most patients used spiritual therapy, and a minority of patients used alternative systems. Complementary and alternative medicine was primarily used for spiritual reasons and the likelihood of its use was influenced by family, friends, and other patients. Patients continued using CM with one or more CAM therapies without informing their healthcare providers, which is a major health risk.
Literature
1.
go back to reference Busato A, Künzi B. Differences in the quality of interpersonal care in complementary and conventional medicine. BMC Complement Altern Med. 2010;10:63.CrossRefPubMedPubMedCentral Busato A, Künzi B. Differences in the quality of interpersonal care in complementary and conventional medicine. BMC Complement Altern Med. 2010;10:63.CrossRefPubMedPubMedCentral
2.
go back to reference Verhoef MJ, Boon HS, Page SA. Talking to cancer patients about complementary therapies: is it the physician’s responsibility? Curr Oncol. 2008;15Suppl 2:s88-s93. Verhoef MJ, Boon HS, Page SA. Talking to cancer patients about complementary therapies: is it the physician’s responsibility? Curr Oncol. 2008;15Suppl 2:s88-s93.
3.
go back to reference Clement YN, Morton-Gittens J, Basdeo L, Blades A, Francis M, Gomes N, et al. Perceived efficacy of herbal remedies by users accessing primary healthcare in Trinidad. BMC Complement Altern Med. 2007;7:4.CrossRefPubMedPubMedCentral Clement YN, Morton-Gittens J, Basdeo L, Blades A, Francis M, Gomes N, et al. Perceived efficacy of herbal remedies by users accessing primary healthcare in Trinidad. BMC Complement Altern Med. 2007;7:4.CrossRefPubMedPubMedCentral
4.
go back to reference Bishop FL, Lewith GT. Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use. Evid Based Complement Alternat Med. 2010;7:11–28.CrossRefPubMed Bishop FL, Lewith GT. Who uses CAM? A narrative review of demographic characteristics and health factors associated with CAM use. Evid Based Complement Alternat Med. 2010;7:11–28.CrossRefPubMed
5.
go back to reference Falci L, Shi Z, Greenlee H. Multiple chronic conditions and use of complementary and alternative medicine among US adults: results from the 2012 National Health Interview Survey. Prev Chronic Dis. 2016;13:150501.CrossRef Falci L, Shi Z, Greenlee H. Multiple chronic conditions and use of complementary and alternative medicine among US adults: results from the 2012 National Health Interview Survey. Prev Chronic Dis. 2016;13:150501.CrossRef
6.
go back to reference Arthur K, Belliard JC, Hardin SB, Knecht K, Chen C-S, Montgomery S. Reasons to use and disclose use of complementary medicine use—an insight from cancer patients. Cancer Clin Oncol. 2013;2:81–92.PubMedPubMedCentral Arthur K, Belliard JC, Hardin SB, Knecht K, Chen C-S, Montgomery S. Reasons to use and disclose use of complementary medicine use—an insight from cancer patients. Cancer Clin Oncol. 2013;2:81–92.PubMedPubMedCentral
8.
go back to reference Birdee GS, Phillips RS, Brown RS. Use of complementary and alternative medicine among patients with end-stage renal disease. Evid Based Complement Alternat Med. 2013;2013:654109.CrossRefPubMedPubMedCentral Birdee GS, Phillips RS, Brown RS. Use of complementary and alternative medicine among patients with end-stage renal disease. Evid Based Complement Alternat Med. 2013;2013:654109.CrossRefPubMedPubMedCentral
9.
go back to reference Cooke M, Mitchell M, Tiralongo E, Murfield J. Complementary and alternative medicine and critical care nurses: a survey of knowledge and practices in Australia. Aust Crit Care. 2012;25:213–23.CrossRefPubMed Cooke M, Mitchell M, Tiralongo E, Murfield J. Complementary and alternative medicine and critical care nurses: a survey of knowledge and practices in Australia. Aust Crit Care. 2012;25:213–23.CrossRefPubMed
10.
go back to reference Pagán JA, Pauly MV. Access to conventional medical care and the use of complementary and alternative medicine. Health Aff (Millwood).2005;24:255–62. Pagán JA, Pauly MV. Access to conventional medical care and the use of complementary and alternative medicine. Health Aff (Millwood).2005;24:255–62.
11.
go back to reference Bahall M, Edwards M. Perceptions of complementary and alternative medicine among cardiac patients in South Trinidad: a qualitative study. BMC Complement Altern Med. 2015;15:99.CrossRefPubMedPubMedCentral Bahall M, Edwards M. Perceptions of complementary and alternative medicine among cardiac patients in South Trinidad: a qualitative study. BMC Complement Altern Med. 2015;15:99.CrossRefPubMedPubMedCentral
13.
go back to reference Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract. 2012;66:924–39.CrossRefPubMed Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract. 2012;66:924–39.CrossRefPubMed
15.
go back to reference Posadzki P, Watson LK, Alotaibi A, Ernst E. Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys. Clin Med. 2013;13:126–31.CrossRef Posadzki P, Watson LK, Alotaibi A, Ernst E. Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys. Clin Med. 2013;13:126–31.CrossRef
16.
go back to reference Xue CC, Zhang AL, Lin V, Da Costa C, Story DF. Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med. 2007;13:643–50.CrossRefPubMed Xue CC, Zhang AL, Lin V, Da Costa C, Story DF. Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med. 2007;13:643–50.CrossRefPubMed
17.
go back to reference Ernst E, White A. The BBC survey of complementary medicine use in the UK. Complement Ther Med. 2000;8:32–6.CrossRefPubMed Ernst E, White A. The BBC survey of complementary medicine use in the UK. Complement Ther Med. 2000;8:32–6.CrossRefPubMed
18.
go back to reference Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010;55:515–25.CrossRefPubMedPubMedCentral Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010;55:515–25.CrossRefPubMedPubMedCentral
19.
go back to reference Firenzuoli F, Gori L. Herbal medicine today: clinical and research issues. Evid Based Complement Alternat Med. 2007;4Suppl 1:37–40. Firenzuoli F, Gori L. Herbal medicine today: clinical and research issues. Evid Based Complement Alternat Med. 2007;4Suppl 1:37–40.
20.
go back to reference Clement Y. Limited clinical evidence to support the integration of Caribbean herbs into conventional medicine. Focus Altern Complement Ther. 2011;16:289–92.CrossRef Clement Y. Limited clinical evidence to support the integration of Caribbean herbs into conventional medicine. Focus Altern Complement Ther. 2011;16:289–92.CrossRef
21.
go back to reference Moyne L, Stubbs R, Crowdy RE, Citrine W, Mackinnon P, Blacklock MG, et al. West India royal commission report. London, UK: Her Majesty’s Stationery Office; 1945. (Command 6607) Moyne L, Stubbs R, Crowdy RE, Citrine W, Mackinnon P, Blacklock MG, et al. West India royal commission report. London, UK: Her Majesty’s Stationery Office; 1945. (Command 6607)
22.
go back to reference Gorji MA, Mahdavi A, Janati Y, Illayi E, Yazdani J, Setareh J, et al. Physiological and psychosocial stressors among hemodialysis patients in educational hospitals of northern Iran. Indian J Palliat Care. 2013;19:166–9.CrossRefPubMedPubMedCentral Gorji MA, Mahdavi A, Janati Y, Illayi E, Yazdani J, Setareh J, et al. Physiological and psychosocial stressors among hemodialysis patients in educational hospitals of northern Iran. Indian J Palliat Care. 2013;19:166–9.CrossRefPubMedPubMedCentral
23.
go back to reference Finnegan-John J, Thomas VJ. The psychosocial experience of patients with end-stage renal disease and its impact on quality of life: findings from a needs assessment to shape a service. ISRN Nephrol. 2012;2013:308986.PubMedPubMedCentral Finnegan-John J, Thomas VJ. The psychosocial experience of patients with end-stage renal disease and its impact on quality of life: findings from a needs assessment to shape a service. ISRN Nephrol. 2012;2013:308986.PubMedPubMedCentral
24.
go back to reference Tejada-Tayabas LM, Partida-Ponce KL, Hernández-Ibarra LE. Coordinated hospital-home care for kidney patients on hemodialysis from the perspective of nursing personnel. Rev Lat Am Enfermagem. 2015;23:225–33.CrossRefPubMedPubMedCentral Tejada-Tayabas LM, Partida-Ponce KL, Hernández-Ibarra LE. Coordinated hospital-home care for kidney patients on hemodialysis from the perspective of nursing personnel. Rev Lat Am Enfermagem. 2015;23:225–33.CrossRefPubMedPubMedCentral
25.
go back to reference Thorsteinsdottir B, Swetz KM, Feely MA, Mueller PS, Williams AW. Are there alternatives to hemodialysis for the elderly patient with end-stage renal failure? Mayo Clin Proc. 2012;87:514–6.CrossRefPubMedPubMedCentral Thorsteinsdottir B, Swetz KM, Feely MA, Mueller PS, Williams AW. Are there alternatives to hemodialysis for the elderly patient with end-stage renal failure? Mayo Clin Proc. 2012;87:514–6.CrossRefPubMedPubMedCentral
26.
go back to reference Roberts L, Ramsaroop K, Seemungal T. Survival outcomes in renal transplantation in Trinidad and Tobago SORTTT study. West Indian Med J. 2012;61:422–8.CrossRefPubMed Roberts L, Ramsaroop K, Seemungal T. Survival outcomes in renal transplantation in Trinidad and Tobago SORTTT study. West Indian Med J. 2012;61:422–8.CrossRefPubMed
28.
go back to reference Roozbeh J, Hashempur MH, Heydari M. Use of herbal remedies among patients undergoing hemodialysis. Iran J Kidney Dis. 2013;7:492–5.PubMed Roozbeh J, Hashempur MH, Heydari M. Use of herbal remedies among patients undergoing hemodialysis. Iran J Kidney Dis. 2013;7:492–5.PubMed
29.
go back to reference Lin MC, Nahin P, Gershwin EM, Longhurst JC, Wu KK. State of complementary and alternative medicine in cardiovascular, lung, and blood research. Circulation. 2001;103:2038–41.CrossRefPubMed Lin MC, Nahin P, Gershwin EM, Longhurst JC, Wu KK. State of complementary and alternative medicine in cardiovascular, lung, and blood research. Circulation. 2001;103:2038–41.CrossRefPubMed
32.
go back to reference Shamsuddin N, Gnanasan S, Karuppanan M, Farooqui M. Complementary and alternative medicine (CAM) in chronic kidney disease (CKD): more evidence needed. AlternIntegr Med. 2016;5:223. doi:10.4172/2327-5162.1000223. Shamsuddin N, Gnanasan S, Karuppanan M, Farooqui M. Complementary and alternative medicine (CAM) in chronic kidney disease (CKD): more evidence needed. AlternIntegr Med. 2016;5:223. doi:10.​4172/​2327-5162.​1000223.
33.
go back to reference Kesavadev J. Efficacy and safety concerns regarding complementary and alternative medicine use among diabetes patients. J Pak Med Assoc. 2017;67:316–9.PubMed Kesavadev J. Efficacy and safety concerns regarding complementary and alternative medicine use among diabetes patients. J Pak Med Assoc. 2017;67:316–9.PubMed
34.
go back to reference Ventola CL. Current issues regarding complementary and alternative medicine (CAM) in the United States; part 2: regulatory and safety concerns and proposed governmental policy changes with respect to dietary supplements. PT. 2010;35:514–22. Ventola CL. Current issues regarding complementary and alternative medicine (CAM) in the United States; part 2: regulatory and safety concerns and proposed governmental policy changes with respect to dietary supplements. PT. 2010;35:514–22.
36.
go back to reference Hill FJ. Complementary and alternative medicine: the next generation of health promotion? Health Promot Int. 2003;18:265–72.CrossRefPubMed Hill FJ. Complementary and alternative medicine: the next generation of health promotion? Health Promot Int. 2003;18:265–72.CrossRefPubMed
38.
39.
go back to reference Krejice RV, Morgan DW. Determining sample size for research activities. Educ Psychol Meas. 1970;30:607–10.CrossRef Krejice RV, Morgan DW. Determining sample size for research activities. Educ Psychol Meas. 1970;30:607–10.CrossRef
40.
go back to reference Duncan HJ, Pittman S, Govil A. Sorn L. Bissler G, Schultz T, et al. Alternative medicine use in dialysis patients: potential for good and bad! Nephron Clin Pract. 2007;105:c108-c113. doi:10.1159/000097986. Duncan HJ, Pittman S, Govil A. Sorn L. Bissler G, Schultz T, et al. Alternative medicine use in dialysis patients: potential for good and bad! Nephron Clin Pract. 2007;105:c108-c113. doi:10.​1159/​000097986.
42.
go back to reference ArjunaRao AS, Phaneendra D, Pavani CD, Soundararajan P, Rani NV, Thennarasu P, et al. Usage of complementary and alternative medicine among patients with chronic kidney disease on maintenance hemodialysis. J Pharm Bioallied Sci. 2016;8:52–7. doi:10.4103/0975-7406.171692.CrossRef ArjunaRao AS, Phaneendra D, Pavani CD, Soundararajan P, Rani NV, Thennarasu P, et al. Usage of complementary and alternative medicine among patients with chronic kidney disease on maintenance hemodialysis. J Pharm Bioallied Sci. 2016;8:52–7. doi:10.​4103/​0975-7406.​171692.CrossRef
44.
45.
go back to reference Clement YN, Williams AF, Aranda D, Chase R, Watson N, Mohammed R, et al. Medicinal herb use among asthmatic patients attending a specialty care facility in Trinidad. BMC Complement Altern Med. 2005;5:3.CrossRefPubMedPubMedCentral Clement YN, Williams AF, Aranda D, Chase R, Watson N, Mohammed R, et al. Medicinal herb use among asthmatic patients attending a specialty care facility in Trinidad. BMC Complement Altern Med. 2005;5:3.CrossRefPubMedPubMedCentral
46.
go back to reference Finkelstein FO, West W, Gobin J, Finkelstein SH, Wuerth D. Spirituality, quality of life and the dialysis patient. Nephrol Dial Transplant. 2007;22:2432–4.CrossRefPubMed Finkelstein FO, West W, Gobin J, Finkelstein SH, Wuerth D. Spirituality, quality of life and the dialysis patient. Nephrol Dial Transplant. 2007;22:2432–4.CrossRefPubMed
50.
go back to reference Chan AL, Leung HW, Wu JW, Chien TW. Risk of hemorrhage associated with co-prescriptions for Ginkgo biloba and antiplatelet or anticoagulant drugs. J Altern Complement Med. 2011;17:513–7.CrossRefPubMed Chan AL, Leung HW, Wu JW, Chien TW. Risk of hemorrhage associated with co-prescriptions for Ginkgo biloba and antiplatelet or anticoagulant drugs. J Altern Complement Med. 2011;17:513–7.CrossRefPubMed
51.
go back to reference Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with Ginkgo biloba: a case report and systematic review of the literature. J Gen Intern Med. 2005;20:657–61.CrossRefPubMedPubMedCentral Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with Ginkgo biloba: a case report and systematic review of the literature. J Gen Intern Med. 2005;20:657–61.CrossRefPubMedPubMedCentral
52.
go back to reference Ge B, Zhang Z, Zuo Z. Updates on the clinical evidenced herb–warfarin interactions. Evid Based Complement Alternat Med. 2014;2014:957362.PubMedPubMedCentral Ge B, Zhang Z, Zuo Z. Updates on the clinical evidenced herb–warfarin interactions. Evid Based Complement Alternat Med. 2014;2014:957362.PubMedPubMedCentral
53.
go back to reference Rabito MJ, Kaye DA. Complementary and alternative medicine and cardiovascular disease: an evidenced-based review. Evid Based Complement Alternat Med. 2013;2013:672097.CrossRefPubMedPubMedCentral Rabito MJ, Kaye DA. Complementary and alternative medicine and cardiovascular disease: an evidenced-based review. Evid Based Complement Alternat Med. 2013;2013:672097.CrossRefPubMedPubMedCentral
55.
go back to reference Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2005;59:425–32.CrossRefPubMedPubMedCentral Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, et al. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2005;59:425–32.CrossRefPubMedPubMedCentral
56.
go back to reference Taki Y, Yokotani K, Yamada S, Shinozuka K, Kubota Y, Watanabe Y, et al. Ginkgo biloba Extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome P450 enzymes by bilobalide in mice. Phytomedicine. 2012;19:177–82.CrossRefPubMed Taki Y, Yokotani K, Yamada S, Shinozuka K, Kubota Y, Watanabe Y, et al. Ginkgo biloba Extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome P450 enzymes by bilobalide in mice. Phytomedicine. 2012;19:177–82.CrossRefPubMed
57.
go back to reference Kim DC, Ku SK, Bae JS. Anticoagulant activities of curcumin and its derivative. BMB Rep. 2012;45:221–6.CrossRefPubMed Kim DC, Ku SK, Bae JS. Anticoagulant activities of curcumin and its derivative. BMB Rep. 2012;45:221–6.CrossRefPubMed
58.
go back to reference Zhong Y, Deng Y, Chen Y, Chuang PY, He JC. Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases. Kidney Int. 2013;84:1108–18.CrossRefPubMedPubMedCentral Zhong Y, Deng Y, Chen Y, Chuang PY, He JC. Therapeutic use of traditional Chinese herbal medications for chronic kidney diseases. Kidney Int. 2013;84:1108–18.CrossRefPubMedPubMedCentral
59.
go back to reference Nowack R, Ballé C, Birnkammer F, Koch W, Sessler R, Birck R. Complementary and alternative medications consumed by renal patients in southern Germany. J Ren Nutr. 2009;19:211–9.CrossRefPubMed Nowack R, Ballé C, Birnkammer F, Koch W, Sessler R, Birck R. Complementary and alternative medications consumed by renal patients in southern Germany. J Ren Nutr. 2009;19:211–9.CrossRefPubMed
60.
go back to reference Markell MS. Potential benefits of complementary medicine modalities in patients with chronic kidney disease. Adv Chronic Kidney Dis. 2005;12:292–9.CrossRefPubMed Markell MS. Potential benefits of complementary medicine modalities in patients with chronic kidney disease. Adv Chronic Kidney Dis. 2005;12:292–9.CrossRefPubMed
61.
go back to reference Hyodo T, Taira T, Takemura T, Yamamoto S, Tsuchida M, Yoshida K, et al. Immediate effect of Shakuyaku-kanzo-to on muscle cramp in hemodialysis patients. Nephron Clin Pract. 2006;104:c28–32.CrossRefPubMed Hyodo T, Taira T, Takemura T, Yamamoto S, Tsuchida M, Yoshida K, et al. Immediate effect of Shakuyaku-kanzo-to on muscle cramp in hemodialysis patients. Nephron Clin Pract. 2006;104:c28–32.CrossRefPubMed
62.
go back to reference Huang JC, Li JH, Liu TX. Effect of combined therapy with hypha Cordyceps and ginkgo leaf tablet on micro inflammation in patients undergoing maintenance hemodialysis. Zhongguo Zhong xi Yi Jie he ZaZhi [Chinese journal of integrated traditional and western medicine]. 2008;28(6):502-4. Article in Chinese. Huang JC, Li JH, Liu TX. Effect of combined therapy with hypha Cordyceps and ginkgo leaf tablet on micro inflammation in patients undergoing maintenance hemodialysis. Zhongguo Zhong xi Yi Jie he ZaZhi [Chinese journal of integrated traditional and western medicine]. 2008;28(6):502-4. Article in Chinese.
63.
go back to reference Barbadoro P, Chiatti C, D’Errico MM, Minelli A, Pennacchietti L, Ponzio E, et al. Complementary and alternative medicine (CAM) among adults in Italy: use and related satisfaction. Eur J Integr Med. 2011;3:e325–32.CrossRef Barbadoro P, Chiatti C, D’Errico MM, Minelli A, Pennacchietti L, Ponzio E, et al. Complementary and alternative medicine (CAM) among adults in Italy: use and related satisfaction. Eur J Integr Med. 2011;3:e325–32.CrossRef
64.
go back to reference Tangkiatkumjai M, Boardman H, Praditpornsilpa K, Walker DM. Reasons why Thai patients with chronic kidney disease use or do not use herbal and dietary supplements. BMC Complement Altern Med. 2014;14:473.CrossRefPubMedPubMedCentral Tangkiatkumjai M, Boardman H, Praditpornsilpa K, Walker DM. Reasons why Thai patients with chronic kidney disease use or do not use herbal and dietary supplements. BMC Complement Altern Med. 2014;14:473.CrossRefPubMedPubMedCentral
65.
go back to reference Warren N, Canaway R, Unantenne N, Manderson L. Taking control: complementary and alternative medicine in diabetes and cardiovascular disease management. Health (London). 2013;17:323–39. doi:10.1177/1363459312460699.CrossRef Warren N, Canaway R, Unantenne N, Manderson L. Taking control: complementary and alternative medicine in diabetes and cardiovascular disease management. Health (London). 2013;17:323–39. doi:10.​1177/​1363459312460699​.CrossRef
66.
go back to reference Hussain S, Malik F. Integration of complementary and traditional medicines in public health care systems: challenges and methodology. J Med Plant Res. 2013;7:2952–9. Hussain S, Malik F. Integration of complementary and traditional medicines in public health care systems: challenges and methodology. J Med Plant Res. 2013;7:2952–9.
Metadata
Title
Use of complementary and alternative medicine by patients with end-stage renal disease on haemodialysis in Trinidad: A descriptive study
Author
Mandreker Bahall
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-1755-7

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue